Certolizumab pegol in pregnant and breastfeeding psoriatic patients

Ital J Dermatol Venerol. 2022 Aug;157(4):383-384. doi: 10.23736/S2784-8671.22.07164-X. Epub 2022 Mar 11.

Authors

Sara Lambiase¹, Chiara Pensa², Ruslana G Shumak², Luca Bianchi², Annunziata Dattola²

Affiliations

¹ Department of Dermatology, Tor Vergata University Hospital, Rome, Italy - sara.lambiase@alice.it.
² Department of Dermatology, Tor Vergata University Hospital, Rome, Italy.

PMID: 35274878
DOI: 10.23736/S2784-8671.22.07164-X

No abstract available

MeSH terms

Antirheumatic Agents* / therapeutic use
Arthritis, Psoriatic* / drug therapy
Breast Feeding
Certolizumab Pegol / therapeutic use
Female
Humans
Pregnancy

Substances

Antirheumatic Agents
Certolizumab Pegol